Botanical species · safety record

Helleborus orientalis

The EFSA Compendium of Botanicals holds 3 constituent measurements for Helleborus orientalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Helleborus orientalis Lam.

3Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Anemonin1
  • Hellebosaponins1
  • Steroidal furostan saponins1

Plant parts

  • Roots and other underground parts2
  • Leaves1

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
HellebosaponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal furostan saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AnemoninLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. KAVALALI, G. ISOLATION OF ANEMONIN FROM HELLEBORUS-ORIENTALIS. LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1976, vol. 39, no. 2-3, p. 178-179.
  2. Mimaki, Y., Watanabe, K., Sakuma, C., Sakagami, H., Sashida, Y. Novel polyoxygenated spirostanol glycosides from the rhizomes of Helleborus orientalis. HELVETICA CHIMICA ACTA, 2003, vol. 86, no. 2, p. 398-407. DOI
  3. Mimaki, Yoshihiro., Matsuo, Yukiko., Watanabe, Kazuki., Sakagami, Hiroshi. Furostanol glycosides from the rhizomes of Helleborus orientalis. JOURNAL OF NATURAL MEDICINES, 2010, vol. 64, no. 4, p. 452-459. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue